F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works

[VUBot]

Aducanumab, or Aduhelm, is the first new Alzheimer’s treatment in 18 years and the first to attack the disease process. But some experts...

Continue reading...